Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

GRIN2A (NR2A): a gene contributing to glutamatergic involvement in schizophrenia.

Journal article

Harrison PJ. and Bannerman DM., (2023), Mol Psychiatry

Data-driven Taxonomy for Antipsychotic Medication: A New Classification System

Journal article

McCutcheon R., (2023), Biological Psychiatry

Neuropsychiatric disorders following SARS-CoV-2 infection

Journal article

HARRISON P. and Taquet M., (2023), Brain

Little evidence supports gabapentinoid use in bipolar disorder or insomnia

Journal article

Saul H. et al, (2022), BMJ (Clinical research ed.), 379

Cervical lymph nodes and ovarian teratomas as germinal centres in NMDA receptor-antibody encephalitis.

Journal article

Al-Diwani A. et al, (2022), Brain, 145, 2742 - 2754

New drug targets in psychiatry: Neurobiological considerations in the genomics era.

Journal article

Harrison PJ. et al, (2022), Neurosci Biobehav Rev, 139

Response to the letter by Lin et al.

Journal article

Taquet M. et al, (2022), Brain Behav Immun, 104

Brain-penetrant calcium channel blockers are associated with a reduced incidence of neuropsychiatric disorders.

Journal article

HARRISON P. and COLBOURNE C., (2022), Molecular Psychiatry

Load More